Hit with allegations in the western media about unethical practices in conducting clinical trials, The Indian government and regulatory authorities are making a bolder move planning mandatory biometric identification for clinical trial volunteers in India. The Ministry of Health and Family Welfare plans to ask all clinical research organisations to enforce biometric identification for the [...]
Filed under: Clinical Trial, Next Generation Clinical Trial, Next Generation Drug Development, Next Generation Drug Discovery | Tagged: health sciences global business unit, Oracle health sciences global business unit | 1 Comment »











